MDK-703

· Medikine, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MDK-703, covering 2024-05-08 to 2024-05-08. Get the full timeline:

Most recent: Clinical Trial Update: A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers [Phase 1]